Clinical Professor Robert Greenwald discusses PEPFAR’s impact at home in the United States, policy barriers to "getting to zero," and ways to address the epidemic head-on.
The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) is undertaking a new advocacy campaign to enforce the health care rights guaranteed by the Affordable Care Act (ACA) for people living with HIV and other chronic conditions.
There is now a cure for Hepatitis C. But in some states, Medicaid won’t pay for it until patients become seriously and irrevocably ill. Harvard Law’s Center for Health Law and Policy Innovation is trying to change that—through research, advocacy and litigation.
Harvard Law School’s Center for Health Law and Policy Innovation (CHLPI) filed an amicus brief to the U.S. Supreme Court in Zubik v. Burwell, an Affordable Care Act (ACA) challenge set for argument on March 26. The brief asks the Court to affirm Court of Appeals’ decisions upholding the federal policy of maintaining access to free preventive care, including contraceptive services, in employer-sponsored health plans.
Participants in a recent gathering at Harvard Law School are hoping to spark the growth of a nationwide student network for making significant contributions to the emerging field of food law and policy.
Robert Greenwald, director of the Center for Health Law and Policy Innovation and a clinical professor of law at Harvard Law School, has co-authored an editorial with David Holtgrave, Ph.D., professor and chair of the Department of Health, Behavior and Society at Johns Hopkins Bloomberg School of Public Health, on the updated National HIV/AIDS Strategy (NHAS) from the federal government.
A team of researchers from Harvard Law School’s Center for Health Law and Policy Innovation, Brown University’s Department of Medicine, Rhode Island’s Miriam Hospital, Treatment Action Group, and Kirby Institute of Australia, has released findings from a nationwide study of Medicaid policies for the treatment of hepatitis C virus (HCV), which affects over 3 million Americans.
On May 19, the Harvard Law School Center for Health Law and Policy Innovation (CHLPI) launched a campaign to promote federal law and policy reforms for type 2 diabetes prevention and management as part of CHLPI’s broader, multi-phase Providing Access to Healthy Solutions (PATHS) initiative that first worked to strengthen local and state policy to address diet-related health conditions.
While the health care rights of low-income individuals living with chronic illnesses are under attack by interests seeking to undermine the Affordable Care Act, advocacy by Harvard Law School’s Center for Health Law and Policy Innovation (CHLPI) has directly led to one health insurance provider making a significant change to protect its patients.
The Harvard Law School Center for Health Law and Policy Innovation has spearheaded the filing of an amicus brief in the U.S. Supreme Court, requesting that the Court affirm a court of appeals decision upholding the nationwide provision of federal subsidies under the Affordable Care Act.